Supporting the next generation of scientists to lead cancer immunology research

Elise Alspach, Ryan D. Chow, Shadmehr Demehri*, Jennifer L. Guerriero, Shashi Gujar, Felix J. Hartmann, Beth A. Helmink, William H. Hudson, Won Jin Ho, Leyuan Ma, Barbara B. Maier, Vivien I. Maltez, Brian C. Miller, Amy E. Moran, Erin M. Parry, Padmini S. Pillai, Sarwish Rafiq, Miguel Reina-Campos, Pamela C. Rosato, Nils Petter RudqvistMegan K. Ruhland, Idit Sagiv-Barfi, Avinash Das Sahu, Robert M. Samstein, Christian M. Schürch, Debattama R. Sen, Daniela S. Thommen, Yochai Wolf, Roberta Zappasodi

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Recent success in the use of immunotherapy for a broad range of cancers has propelled the field of cancer immunology to the forefront of cancer research. As more and more young investigators join the community of cancer immunologists, the Arthur L. Irving Family Foundation Cancer Immunology Symposium provided a platform to bring this expanding and vibrant community together and support the development of the future leaders in the field. This commentary outlines the lessons that emerged from the inaugural symposium highlighting the areas of scientific and career development that are essential for professional growth in the field of cancer immunology and beyond. Leading scientists and clinicians in the field provided their experience on the topics of scientific trajectory, career trajectory, publishing, fundraising, leadership, mentoring, and collaboration. Herein, we provide a conceptual and practical framework for career development to the broader scientific community.

Original languageEnglish
Pages (from-to)1245-1251
Number of pages7
JournalCancer immunology research
Issue number11
StatePublished - Nov 2021
Externally publishedYes


FundersFunder number
National Cancer Institute
Doris Duke Charitable Foundation
Parker Institute for Cancer Immunotherapy
LAM Therapeutics


    Dive into the research topics of 'Supporting the next generation of scientists to lead cancer immunology research'. Together they form a unique fingerprint.

    Cite this